Overview of antiretroviral treatment in China: Advancement and challenges

Chinese Medical Journal

Volumn 124, Issue 3, 2011, Pages 440-444

  Luo, Ling ^a   Li, Tai Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Acquired immure deficiency syndrome; Highly active anti retroviral therapy; Human immunodeficiency virus; National free antiretroviral treatment program

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINA; DRUG EFFICACY; DRUG ERUPTION; DRUG PREFERENCE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EPIDEMIC; HEMATOLOGIC DISEASE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; LATENT TUBERCULOSIS; LIVER TOXICITY; MITOCHONDRIAL TOXICITY; MIXED INFECTION; MORTALITY; PERIPHERAL NEUROPATHY; VERTICAL TRANSMISSION; VIREMIA; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; CHINA; HIV INFECTIONS; HUMANS; LIPODYSTROPHY;

EID: 79551718204     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.03.022     Document Type: Article

References (29)

1. Bureau of Hygiene and Tropical Diseases. Weekly epidemiological record. AIDS Newsletter 1986; 61: 29.
2. Department of Disease Control, Minister of Health, China; National Center for AIDS Prevention and Control; Group of National HIV Sentinel Surveillance. National sentinel surveillance of HIV infection in China from 1995 to 1998. Chin J Epidemiol (Chin) 2000; 21: 7-9.
3. Zheng X. Control of transmission of HIV among drug users and commercial blood donors. Chin J Epidemiol (Chin) 2000; 21: 6.
4. A joint assessment of HIV/AIDS prevention, treatment and care in China (2004). Beijing: State Council AIDS Working Committee Office and UN Theme Group on HIV/AIDS in China, 2004 (Accessed December 1, 2004 at http://www.chinaids.org.cn/worknet/download/2004/report2004en.pdf)
5. A joint assessment of HIV/AIDS prevention, treatment and care in China (2007). Beijing: State Council AIDS Working Committee Office, UN Theme Group on AIDS in China, 2007. (Accessed December 1, 2007 at http://www.un.org.cn/cms/p/resources/30/491/content.html)
6. 2005 Update on the HIV/AIDS epidemic and response in China. Beijing: Ministry of Health of the People's Republic of China, Joint United Nations Programne on HIV/AIDS, World Health Organization, 2006. (Accessed Juanary 24, 2006 at http://data.unaids.org/publications/External-Documents/rp_2005chinaestimation_25jan06_en.pdf)
7. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21 Suppl 8: s143-s148.
8. OL. HIV/AIDS program gets more support. China Daily, 2007-06-19 (3).
9. Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 2009; 151: 241-251.
10. Li T, Dai Y, Kuang J, Jiang J, Han Y, Qiu Z, et al. Three generic nevirapine-based antiretroviral treatments in Chinese HIV/AIDS patients: multicentric observation cohort. PLoS One 2008; 3: e3918.
11. Wang ZQ. New drugs help fight AIDS better. China Daily, 2009-01-20 (1).
12. Antiretroviral therapy of HIV infection in infants and children: towards universal access, recommendations for a public health approach. Geneva: World Health Organization, 2006.
13. Zhao Y, Sun X, He Y, Tang Z, Peng G, Liu A, et al. Progress of the National Pediatric Free Antiretroviral Therapy Program in China. AIDS Care 2010; 22: 1182-1188.
14. Bulterys M, Vermund SH, Chen RY, Ou CY. A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Chin Med J 2009; 122: 1352-1355.
15. Zhou Z, Meyers K, Li X, Chen Q, Qian H, Lao Y, et al. Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China. J Acquir Immune Defic Syndr 2010; 53 Suppl 1: s15-s22.
16. Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, et al. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China. Int J STD AIDS 2009; 20: 249-254.
17. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21 Suppl 8: s143-s148.
18. Zhang F, Haberer JE, Zhao Y, Dou Z, Zhao H, He Y, et al. Chinese pediatric highly active antiretroviral therapy observational cohort a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr 2007; 46: 594-598.
19. Li JY, Li HP, Li L, Li H, Wang Z, Yang K, et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005; 15: 843-849.
20. Xing H, Jiang S, Si X, Cheng H, Shang H, Li J, et al. HIV-1 drug resistance in China: nationwide survey and analysis of impacting factors in the national ARV treatment program. Third International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 2005.
21. Zhang L, Li M, Tao MM, Qiu ZF, Xie J, Han Y, et al. A study of HIV-related lipodystrophy syndrome in 55 HIV-infected Chinese adult patients. Chin J Intern Med (Chin) 2009; 48: 118-121.
22. CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 49 (5 Suppl): s138-s145.
23. Rockstroh JK, Spengler U. HIV and hepatitis C virus co-infection. Lancet Infect Dis 2004; 4: 437-444.
24. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis 2005; 41 Suppl 1: s18-s24.
25. Guo FP, Lü W, Han Y, Qiu ZF, Zuo LY, Li YL, et al. Impact of hepatitis C virus coinfection on HAART in HIV-infected individuals: multicentric observation cohort. J Acquir Immune Defic Syndr 2010; 54: 137-142.
26. Zhang LF, Liu XQ, Zuo LY, Li TS, Deng GH, Wang AX. Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy. Chin Med J 2010; 123: 1117-1121.
27. El-Sadr WM, Tsiouris SJ. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med 2008; 29: 525-531.
28. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007; 369: 679-690.
29. China's evolving response to HIV/AIDS. Lancet 2009; 373: 694.